[{"arm_notes": "", "treatment_id": null, "treatment_name": "FINLAY-FR-1A Experimental Group: 50 \u00b5g of RBD + adjuvant; 0.5 mL by intramuscular route. Treatment scheme: one dose. Presentation: Vial with single dose.;Immunogenicity; Vaccine;Immunotherapy; Active ;Vaccination ;Injections; Intramuscular;Single Dose ;FINLAY-FR-1A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "50\u03bcg;1;IM", "treatment_id": 513, "treatment_name": "Finlay-fr-1a anti-sars-cov-2 vaccine", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "FINLAY-FR-1A Experimental Group: 50 ?g of RBD + adjuvant; 0.5 mL by intramuscular route. Treatment scheme: one dose. Presentation: Vial with single dose.;Immunogenicity; Vaccine;FINLAY-FR-1A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]